·Recent experiments have confirmed the feasibility of a high-precision digital antibody detection technology for the Covid-19 (SARS-CoV-2) virus
Ams semiconductor AS7341L spectral sensor supports reading lateral immunochromatographic detection data through spectral analysis
· Quantitative verification is performed on this platform through C-reactive protein (CRP) detection technology, and the detection concentration can be as low as tens of pg/ml, which is 10 times higher than the detection sensitivity of most standard rapid detection and readout equipment
·The platform is low-cost, suitable for doctor’s office and other instant occasions
·Quick detection provides objective results without user interpretation, and can be transmitted to smart phone applications via Bluetooth
China, June 15, 2020-the world’s leading high-performance sensor solutions provider ams Semiconductor (ams AG, Swiss stock exchange ticker symbol: AMS) and Senova (a German-based manufacturer of in vitro diagnostic medical equipment) It was announced today that the two companies have worked together to successfully complete the test using Senova technology and ams semiconductor spectroscopic sensor technology, which can improve the lateral chromatography detection for Covid-19 (SARS-CoV-2) virus-related antibody detection. Performance and availability. Based on the AS7341L spectral sensor, ams has developed a sensor module that can read lateral immunochromatographic detection data through spectral analysis.
The combined test of ams spectroscopic sensor technology and Senova’s commercial serum IgG/M Covid-19 detection (Cleartest?) technology has been successful. Senova’s detection technology is used to confirm the diagnosis in the later stage of the disease and large-scale antibody screening projects.
Based on this successful test, ams Semiconductor and Senova have established a partnership to combine the readout technology of ams with Senova’s lateral tomography detection function. The two companies decided to jointly develop a disposable Electronic lateral chromatography detection device based on antibody detection to achieve immunity detection against the Covid-19 (SARS-CoV-2) virus.
The equipment adopts lateral tomography detection technology and spectral sensors, which will be able to read out quantitative detection data accurately, cost-effectively and efficiently, and provide objective results without user interpretation. Compared with the existing PCR detection method, the detection kit has low cost and is suitable for doctor’s office and other immediate occasions.
Recent experiments have further proved the feasibility of quantitative detection of serum proteins (such as C-reactive protein (CRP)), and the detection concentration can be as low as tens of pg/ml (picg/ml). This is more than 10 times higher than the detection sensitivity of most standard rapid detection and readout devices. If combined with the Covid-19 (SARS-CoV-2) antigen test, it can also be used for Covid-19 (SARS-CoV-2) in the early stage of Covid-19 (SARS-CoV-2) through saliva and nasal swab samples. ) Virus detection provides a platform, which will be the next development goal.
In order to reach production scale faster, ams will cooperate with leading healthcare manufacturing solutions provider Jabil Healthcare
Aims to provide a high-precision, disposable, low-cost device to the market, which will help competent authorities, healthcare providers and other care institutions to achieve urgently needed immediate antibody testing faster, so that there is no need to waste time on antibody test strips Send to remote laboratory. The device has a low price and can be easily connected to a smartphone application or uploaded to the cloud, so the raw spectrum data can be sent to a local Bluetooth-enabled device (such as a smart phone) for reading. This data can also be further transmitted to the cloud for evaluation. The results are then transmitted back to the local Bluetooth device, and if the user needs, these extensive test results information can also be incorporated into the national or international monitoring system. For sensitive user data, appropriate measures will be taken to protect it, such as data encryption and privacy policies.
Ams, Senova, and Jabil are expected to increase the output of this CE-certified one-time professional testing kit for medical products by September 2020, and ams’ next goal is to provide home-certified equipment.
Jennifer Zhao, Executive Vice President of the Advanced Optical Sensors Division of ams, said: “For healthcare applications, ams’ innovations through miniaturized and cost-effective spectroscopic sensor technology are more valuable than ever. Rapid detection equipment The colorimetric and fluorescent information can be detected by a small and powerful optical sensor, which supports extensive detection of viruses and antibodies at low cost. We hope to use this technology to contribute to the fight against the current global pandemic.”
“This collaborative project is a great opportunity to provide a new generation of instant detection, which not only fundamentally improves accuracy, but also achieves excellent processing efficiency. The digital Covid-19 antibody detection kit will be the next one that currently supports global healthcare providers. Important products,” Senova CEO Hans Hermann Söffing added.
“Jabil Healthcare is pleased to support ams and Senova to jointly develop and mass-produce digital disposable lateral tomography detection solutions. Our European design and development team will provide the highest level of innovation within a limited time . With our global footprint, strict supervision, and extensive experience in the production of electronic components and sub-components for the diagnostic industry, we will provide support to meet the global needs of ams, Senova, and partners who visit the platform.” Said David Panneton, vice president of diagnostic products at Jabil Healthcare.
For more information about the ams semiconductor AS7341L
About ams Semiconductor
Ams Semiconductor designs and manufactures high-performance analog sensor solutions. The company’s vision is to provide seamless interaction between people and technology through sensor solutions to create a perfect world.
Ams’ high-performance sensor solutions are committed to promoting applications that require small appearance, low power consumption, high sensitivity, and multi-sensor integration. The company mainly provides products including sensor solutions, sensor ICs, interfaces and related software to customers in the consumer, communications, industrial, medical and automotive markets.
Ams Semiconductor is headquartered in Austria, employs approximately 8,500 people worldwide, and provides services to more than 8,000 customers all over the world. Ams is listed on the Swiss Stock Exchange (stock code-Swiss Stock Exchange: AMS). For more information, please visit www.ams.com.
Welcome to follow the official WeChat account (ams semiconductor) for more information.
Ams Semiconductor (ams) is a registered trademark of Ams Semiconductor Group (ams AG). In addition, many of our products and services are registered or have trademarks under the Ams Semiconductor Group. The names of all other companies or products mentioned in this press release are either trademarks or registered trademarks of their owners. The information provided in the press release was accurate at the time of publication, and will be subject to change without notice.
Get more information
Media Relations Ams Semiconductor Amy Flécher Vice President of Marketing Communications Tel +43 664 8816 2121 [email protected] ams.com
Technical Contact Ams Semiconductor Filip Frederix Product Marketing Manager Tel +43 3136 5000 [email protected] ams.com
Media Contact: George Qiao, GeoMatrix PR Company Tel: +86 10 8595 1439 [email protected]